Literature DB >> 27518565

Dual Chromatin and Cytoskeletal Remodeling by SETD2.

In Young Park1, Reid T Powell1, Durga Nand Tripathi1, Ruhee Dere1, Thai H Ho2, T Lynne Blasius3, Yun-Chen Chiang4, Ian J Davis5, Catherine C Fahey4, Kathryn E Hacker4, Kristen J Verhey3, Mark T Bedford6, Eric Jonasch7, W Kimryn Rathmell8, Cheryl Lyn Walker9.   

Abstract

Posttranslational modifications (PTMs) of tubulin specify microtubules for specialized cellular functions and comprise what is termed a "tubulin code." PTMs of histones comprise an analogous "histone code," although the "readers, writers, and erasers" of the cytoskeleton and epigenome have heretofore been distinct. We show that methylation is a PTM of dynamic microtubules and that the histone methyltransferase SET-domain-containing 2 (SETD2), which is responsible for H3 lysine 36 trimethylation (H3K36me3) of histones, also methylates α-tubulin at lysine 40, the same lysine that is marked by acetylation on microtubules. Methylation of microtubules occurs during mitosis and cytokinesis and can be ablated by SETD2 deletion, which causes mitotic spindle and cytokinesis defects, micronuclei, and polyploidy. These data now identify SETD2 as a dual-function methyltransferase for both chromatin and the cytoskeleton and show a requirement for methylation in maintenance of genomic stability and the integrity of both the tubulin and histone codes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27518565      PMCID: PMC5101839          DOI: 10.1016/j.cell.2016.07.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  49 in total

Review 1.  Limiting the proliferation of polyploid cells.

Authors:  Neil J Ganem; David Pellman
Journal:  Cell       Date:  2007-11-02       Impact factor: 41.582

Review 2.  The tubulin code.

Authors:  Kristen J Verhey; Jacek Gaertig
Journal:  Cell Cycle       Date:  2007-06-26       Impact factor: 4.534

3.  Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.

Authors:  Mark Bi; Siming Zhao; Jonathan W Said; Maria J Merino; Adebowale J Adeniran; Zuoquan Xie; Cayce B Nawaf; Jaehyuk Choi; Arie S Belldegrun; Allan J Pantuck; Harriet M Kluger; Kaya Bilgüvar; Richard P Lifton; Brian Shuch
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-10       Impact factor: 11.205

4.  Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling.

Authors:  Ming Hu; Xiao-Jian Sun; Yuan-Liang Zhang; Ying Kuang; Chao-Quan Hu; Wei-Li Wu; Shu-Hong Shen; Ting-Ting Du; Hong Li; Fei He; Hua-Sheng Xiao; Zhu-Gang Wang; Ting-Xi Liu; He Lu; Qiu-Hua Huang; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

5.  Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.

Authors:  Ailan Guo; Hongbo Gu; Jing Zhou; Daniel Mulhern; Yi Wang; Kimberly A Lee; Vicky Yang; Mike Aguiar; Jon Kornhauser; Xiaoying Jia; Jianmin Ren; Sean A Beausoleil; Jeffrey C Silva; Vidyasiri Vemulapalli; Mark T Bedford; Michael J Comb
Journal:  Mol Cell Proteomics       Date:  2013-10-15       Impact factor: 5.911

6.  SETD2 is required for DNA double-strand break repair and activation of the p53-mediated checkpoint.

Authors:  Sílvia Carvalho; Alexandra C Vítor; Sreerama C Sridhara; Filipa B Martins; Ana C Raposo; Joana M P Desterro; João Ferreira; Sérgio F de Almeida
Journal:  Elife       Date:  2014-05-06       Impact factor: 8.140

7.  High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma.

Authors:  T H Ho; I Y Park; H Zhao; P Tong; M D Champion; H Yan; F A Monzon; A Hoang; P Tamboli; A S Parker; R W Joseph; W Qiao; K Dykema; N M Tannir; E P Castle; R Nunez-Nateras; B T Teh; J Wang; C L Walker; M-C Hung; E Jonasch
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

8.  SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair.

Authors:  N Kanu; E Grönroos; P Martinez; R A Burrell; X Yi Goh; J Bartkova; A Maya-Mendoza; M Mistrík; A J Rowan; H Patel; A Rabinowitz; P East; G Wilson; C R Santos; N McGranahan; S Gulati; M Gerlinger; N J Birkbak; T Joshi; L B Alexandrov; M R Stratton; T Powles; N Matthews; P A Bates; A Stewart; Z Szallasi; J Larkin; J Bartek; C Swanton
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

9.  Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia.

Authors:  Brenton G Mar; Lars B Bullinger; Kathleen M McLean; Peter V Grauman; Marian H Harris; Kristen Stevenson; Donna S Neuberg; Amit U Sinha; Stephen E Sallan; Lewis B Silverman; Andrew L Kung; Luca Lo Nigro; Benjamin L Ebert; Scott A Armstrong
Journal:  Nat Commun       Date:  2014-03-24       Impact factor: 14.919

10.  Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma.

Authors:  Weisi Liu; Qiang Fu; Huimin An; Yuan Chang; Weijuan Zhang; Yu Zhu; Le Xu; Jiejie Xu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more
  79 in total

1.  Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.

Authors:  Toni K Choueiri; Michael B Atkins; Ziad Bakouny; Maria I Carlo; Charles G Drake; Eric Jonasch; Payal Kapur; Bryan Lewis; W Marston Linehan; Michael J Mitchell; Sumanta K Pal; Kevin Pels; Susan Poteat; W Kimryn Rathmell; Brian I Rini; Sabina Signoretti; Nizar Tannir; Robert Uzzo; Christopher G Wood; Hans J Hammers
Journal:  J Natl Cancer Inst       Date:  2021-03-01       Impact factor: 13.506

2.  Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.

Authors:  In-Kyu Kim; Justine N McCutcheon; Guanhua Rao; Stephen V Liu; Yves Pommier; Marcin Skrzypski; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

Review 3.  Lysine Methylation Regulators Moonlighting outside the Epigenome.

Authors:  Evan M Cornett; Laure Ferry; Pierre-Antoine Defossez; Scott B Rothbart
Journal:  Mol Cell       Date:  2019-09-19       Impact factor: 17.970

4.  Identification, Quantification, and System Analysis of Protein N-ε Lysine Methylation in Anucleate Blood Platelets.

Authors:  Anne D Rocheleau; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Özgün Babur; Samuel Tassi Yunga; Anh T P Ngo; Jiaqing Pang; Larry L David; Owen J T McCarty; Joseph E Aslan
Journal:  Proteomics       Date:  2019-05-09       Impact factor: 3.984

5.  Post-translational modifications: Extension of the tubulin code.

Authors:  Paulina Strzyz
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-24       Impact factor: 94.444

6.  Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.

Authors:  Huairui Yuan; Ni Li; Da Fu; Jiale Ren; Jingyi Hui; Junjie Peng; Yongfeng Liu; Tong Qiu; Min Jiang; Qiang Pan; Ying Han; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-08-21       Impact factor: 14.808

Review 7.  The tubulin code and its role in controlling microtubule properties and functions.

Authors:  Carsten Janke; Maria M Magiera
Journal:  Nat Rev Mol Cell Biol       Date:  2020-02-27       Impact factor: 94.444

8.  SETD2 Haploinsufficiency for Microtubule Methylation Is an Early Driver of Genomic Instability in Renal Cell Carcinoma.

Authors:  Yun-Chen Chiang; In-Young Park; Esteban A Terzo; Durga Nand Tripathi; Frank M Mason; Catherine C Fahey; Menuka Karki; Charles B Shuster; Bo-Hwa Sohn; Pratim Chowdhury; Reid T Powell; Ryoma Ohi; Yihsuan S Tsai; Aguirre A de Cubas; Abid Khan; Ian J Davis; Brian D Strahl; Joel S Parker; Ruhee Dere; Cheryl L Walker; W Kimryn Rathmell
Journal:  Cancer Res       Date:  2018-05-03       Impact factor: 12.701

9.  Integrated Genomic and Proteomic Analyses Reveal Novel Mechanisms of the Methyltransferase SETD2 in Renal Cell Carcinoma Development.

Authors:  Lin Li; Weili Miao; Ming Huang; Preston Williams; Yinsheng Wang
Journal:  Mol Cell Proteomics       Date:  2018-11-28       Impact factor: 5.911

10.  Microtubule Acetylation Is Required for Mechanosensation in Drosophila.

Authors:  Connie Yan; Fei Wang; Yun Peng; Claire R Williams; Brian Jenkins; Jill Wildonger; Hyeon-Jin Kim; Jonathan B Perr; Joshua C Vaughan; Megan E Kern; Michael R Falvo; E Timothy O'Brien; Richard Superfine; John C Tuthill; Yang Xiang; Stephen L Rogers; Jay Z Parrish
Journal:  Cell Rep       Date:  2018-10-23       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.